Serialization in Pharmaceuticals, a Webinar Presented by Xtalks - FOX Carolina 21
Member Center:
This article was originally distributed via PRWeb. PRWeb, WorldNow and this Site make no warranties or representations in connection therewith.
SOURCE: Xtalks
Xtalks presents a live webinar on Wednesday, February 27, 2013, 11:00am EST on Serialization in Pharmaceuticals. Industry expert Daljeet Sahni, AD Global Supply Chain for Bristol-Myers Squibb, one of the first companies to understand the multiple benefits of item level serialization, will examine serialization and its use in fighting counterfeit drugs.
Toronto, Canada (PRWEB) February 22, 2013
Serialization provides many benefits in addition to regulatory compliance, including improving patient safety, protecting corporate reputation, enhancing corporate social responsibility, and providing a competitive advantage. There is also value in data collected through serialization efforts. Manufacturers are discovering different ways to make best use of the data being returned by their supply chain partners.
Moreover, counterfeiting of drugs and medical devices costs the pharmaceutical and medical device industry billions of dollars annually in lost revenues. This loss is amplified by the serious threats fake drugs pose to the health and safety of consumers.
A live Q&A with the audience will follow the main presentation. For more information, or to register for this event please go to http://xtks.in/xto570p.
Xtalks, powered by Honeycomb Worldwide Inc., is a leading provider of educational webinars to the global Life Sciences community. Every year thousands of industry practitioners turn to Xtalks for access to quality content. Xtalks helps Life Science professionals stay current with industry developments, trends and regulations. Xtalks webinars also provide perspectives on key issues from top industry thought leaders and service providers.
To learn more about Xtalks visit http://xtalks.com/ContactUs.ashx
Contact:
Karen Lim (416) 977-6555 ext 227
clientservices(at)xtalks(dot)com
For the original version on PRWeb visit: http://www.prweb.com/releases/prweb2013/2/prweb10455751.htm
 | 
|
